Sonosensitized Aggregation-Induced Emission Dots with Capacities of Immunogenic Cell Death Induction and Multivalent Blocking of Programmed Cell Death-Ligand 1 for Amplified Antitumor Immunotherapy

The combination of immunogenic cell death (ICD) induction and immune checkpoint blockade has emerged as a major direction of cancer immunotherapy. Among currently available ICD inducers, sonosensitizers that produce reactive oxygen species (ROS) under an external trigger to evoke ICD of tumor cells have shown great promise. However, a highly efficient sonosensitizer-based ICD inducer with an aggregation-induced emission (AIE) characteristic has yet to be developed. Herein, a novel AIE sonosensitizer with a twisted molecular structure, very small energy gap between the singlet and triplet excited states (Delta E-ST), and efficient ROS generation ability, which can serve as an effective ICD inducer, is reported for sonodynamic processes in cancer immunotherapy. Furthermore, an AIE sonosensitizer-based nanosystem with surface modification of anti-PD-L1 peptide is constructed for boosting antitumor immunotherapy. In this system, AIE sonosensitizer-mediated sonodynamic therapy can successfully convert a hypoimmunogenic cold tumor to a hot one and further facilitate the multivalent blocking of programed death ligand (PD-L1) by anti-PD-L1 peptides. Such an advanced nanosystem could effectively initiate the activation of antitumoral immune reactions and modulation of an immunosuppressive microenvironment, contributing to systemic antitumor effects to further inhibit the growth of distant tumors. [GRAPHICS] .

Automated summary

This study reports a novel AIE sonosensitizer that can induce immunogenic cell death of tumor cells, making it a promising candidate for cancer immunotherapy. Additionally, a nanosystem based on this sonosensitizer and modified with anti-PD-L1 peptide is constructed to enhance antitumor immunotherapy.